StockNews.com Begins Coverage on China Pharma (NYSE:CPHI)

Analysts at StockNews.com initiated coverage on shares of China Pharma (NYSE:CPHIGet Rating) in a research note issued to investors on Monday. The brokerage set a “hold” rating on the stock.

China Pharma Stock Down 8.5 %

Shares of NYSE:CPHI opened at $0.11 on Monday. The firm’s 50 day moving average price is $0.14 and its 200-day moving average price is $0.19. China Pharma has a twelve month low of $0.10 and a twelve month high of $0.67. The stock has a market capitalization of $5.45 million, a PE ratio of -1.32 and a beta of 0.65.

About China Pharma

(Get Rating)

China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products primarily to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.

Further Reading

Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.